DIVISLAB vs FDC: Stock Comparison

Divis Laboratories Ltd vs FDC Limited

Live data: 22 July 2026, 2:59 PM IST • Source: NSE and company filings

Divis Laboratories Ltd is the larger company by market capitalisation. Divis Laboratories Ltd shows a higher ROE, lower leverage and a higher ROCE, while FDC Limited shows a lower P/E, a higher dividend yield and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Divis Laboratories Ltd and FDC Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, DIVISLAB is more favourable on 6 of 13 scored metrics and FDC on 7These counts are context-free and are not an overall rating.

Key Differences

Market Cap
DIVISLAB is the larger company
₹1.96 L Cr vs ₹6,713 Cr
P/E Ratio
FDC has a lower P/E
23.94x vs 75.8x
P/B Ratio
FDC has a lower P/B
2.71x vs 11.61x
EPS
DIVISLAB has higher earnings per share
₹96.6 vs ₹17.3
Dividend Yield
FDC has a higher dividend yield
2.39% vs 0.41%
Revenue Growth (TTM YoY)
FDC has faster revenue growth
18.9% vs 9.5%
EPS Growth (TTM YoY)
FDC has faster EPS growth
166.8% vs 13.6%
Qtr Sales Growth
FDC has stronger quarterly sales growth
18.9% vs 9.52%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricDIVISLABFDC
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricDIVISLABFDC
Live Price₹7,388₹411.75
Day Change0.79%-0.36%
Volume3.23 L1.33 L
52-Week High₹7,438.5₹527.8
52-Week Low₹5,636.5₹312.95
Distance from 52W High-0.68%-21.99%

Valuation

MetricDIVISLABFDC
Market Cap₹1.96 L Cr₹6,713 Cr
P/E Ratio75.8x23.94x
P/B Ratio11.61x2.71x
EPS₹96.6₹17.3
Book Value₹631.37₹152.62
Dividend Yield0.41%2.39%

Growth

MetricDIVISLABFDC
Revenue Growth (TTM YoY)9.5%18.9%
EPS Growth (TTM YoY)13.6%166.8%
Qtr Sales Growth9.52%18.9%
Qtr Profit Growth13.4%167%

Profitability & Leverage

MetricDIVISLABFDC
ROE16.5%12.5%
ROCE22%16.7%
Net Margin24.36%12.96%
Operating Margin32.6%15.9%
Debt to Equity0x0.01x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricDIVISLABFDC
Promoter Holding51.88%69.66%
FII Holding20.2% 0.09 pp1.4% 1 pp
DII Holding19.38% 0.16 pp6.31% 0.02 pp
Public Holding8.54% 0.06 pp22.63% 0.98 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Divis Laboratories Ltd and FDC Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.